Zopiclone and Fatty liver alcoholic - a phase IV clinical study of FDA data


Fatty liver alcoholic is found among people who take Zopiclone, especially for people who are male, 30-39 old.

The phase IV clinical study analyzes which people take Zopiclone and have Fatty liver alcoholic. It is created by eHealthMe based on reports of 41,014 people who have side effects when taking Zopiclone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 12, 2022

41,014 people reported to have side effects when taking Zopiclone.
Among them, 10 people (0.02%) have Fatty liver alcoholic.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 42,615 Zopiclone users for its effectiveness, alternative drugs and more.

What is Fatty liver alcoholic?

Fatty liver alcoholic (fat accumulate in liver cells due to alcohol drinking) is found to be associated with 131 drugs and 46 conditions by eHealthMe.

Number of Zopiclone and Fatty liver alcoholic reports submitted per year:

Could Zopiclone cause Fatty liver alcoholic?

Gender of people who have Fatty liver alcoholic when taking Zopiclone *:

  • female: 12.5 %
  • male: 87.5 %

Age of people who have Fatty liver alcoholic when taking Zopiclone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 85.71 %
  • 40-49: 14.29 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Zopiclone *:

  1. Metformin: 2 people, 20.00%
  2. Clozaril: 2 people, 20.00%
  3. Cymbalta: 1 person, 10.00%

Common side effects people have besides Fatty liver alcoholic *:

  1. Suicide Attempt: 7 people, 70.00%
  2. Overdose: 7 people, 70.00%
  3. Death: 5 people, 50.00%
  4. Quit Smoking: 2 people, 20.00%
  5. Cardiomyopathy Alcoholic: 2 people, 20.00%
  6. Malaise (a feeling of general discomfort or uneasiness): 1 person, 10.00%
  7. Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 1 person, 10.00%

Common conditions people have *:

  1. Alcoholism (problems with alcohol): 7 people, 70.00%
  2. Type 2 Diabetes: 2 people, 20.00%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 20.00%
  4. High Blood Pressure: 2 people, 20.00%
  5. High Blood Cholesterol: 2 people, 20.00%
  6. Constipation: 2 people, 20.00%
  7. Neuropathy Peripheral (surface nerve damage): 1 person, 10.00%
  8. Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 10.00%
  9. Endometrial Cancer: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zopiclone and have Fatty liver alcoholic?

Check whether Fatty liver alcoholic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Fatty liver alcoholic and when was it recovered:

Expand to all the drugs that have ingredients of eszopiclone:

Alternative drugs to, pros and cons of Zopiclone:

Common Zopiclone side effects:

Browse all side effects of Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Fatty liver alcoholic treatments and more:

COVID vaccines that are related to Fatty liver alcoholic:

All the drugs that are associated with Fatty liver alcoholic:

All the conditions that are associated with Fatty liver alcoholic:

How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone (the active ingredients of Zopiclone) and Zopiclone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: